PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Lobbying for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $50,000.00 expenses · posted Apr 18, 2025

Lobbying activity 3

Health Issues

Discussed issues related to drug shortages, pandemic preparedness, advanced manufacturing, onshoring/friendshoring initiatives, and robustness of biopharmaceutical supply chains

Manufacturing

Discussed issues related to drug shortages, pandemic preparedness, advanced manufacturing, onshoring/friendshoring initiatives, and robustness of biopharmaceutical supply chains

Pharmacy

Discussed issues related to drug shortages, pandemic preparedness, advanced manufacturing, onshoring/friendshoring initiatives, and robustness of biopharmaceutical supply chains

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.